Biontech Rna Pharmaceuticals competitive analysis

Latest publications and patents of Biontech Rna Pharmaceuticals New

Explore the latest publications and patents granted to Biontech Rna Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Biontech Rna Pharmaceuticals

Oct 27, 2021Methods For Providing Single-Stranded RnaGranted And Under Opposition
Sep 8, 2021Individualized Vaccines For CancerGranted And Under Opposition
Jul 10, 2019Individualized Vaccines For CancerOpposition Rejected

Explore patent oppositions filed by Biontech Rna Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Method For Producing Rna Molecule CompositionsCUREVACNov 12, 2020
Rna Containing Composition For Treatment Of Tumor DiseasesCUREVACMar 26, 2020

Explore Biontech Rna Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 27, 2021Methods For Providing Single-Stranded Rna1
Sep 8, 2021Individualized Vaccines For Cancer1
Jul 10, 2019Individualized Vaccines For Cancer3

Latest PTAB cases involving Biontech Rna Pharmaceuticals

Discover the latest PTAB cases involving Biontech Rna Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Biontech Rna Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
BIONTECH RNA PHARMACEUTICALS25 - - Balanced
CUREVAC - 62 - 1Non-Active
IPRIME RENTSCH KAELIN1 - - - Highly Aggressive
WITHERS & ROGERS33 - - - Highly Aggressive